Company news
Pluri Inc. news in 2021
Pluri Inc.'s news releases, calls and decks from 2021, newest first.
Pluristem Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture Surgery
November 14, 2021
Pluristem Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors
July 18, 2021
Pluristem Therapeutics Inc. Announces $30 Million Registered Direct Offering
February 1, 2021
Pluristem Announces Uplisting to the Nasdaq Global Market®
January 26, 2021
Pluristem Announces Appointments of Two Directors to Board
January 5, 2021
Decks in 2021
- Pluristem Therapeutics — Corporate Update (May 2021)
Corporate update · 20 slides · May 3, 2021